Medicines and Healthcare products Regulatory Agency
REGISTRATION OF MANUFACTURER, IMPORTER OR DISTRIBUTOR OF ACTIVE SUBSTANCES TO BE USED AS STARTING MATERIALS IN MEDICINAL PRODUCTS FOR HUMAN USE
| 1. Registration Number | UK API 32708 |
| 2. Name or corporate name of registrant | KUEHNE + NAGEL (UK) LIMITED |
| 3. Permanent or legal address of registrant | KUEHNE + NAGEL (UK) LIMITED, 1 ROUNDWOOD AVENUE, STOCKLEY PARK, UXBRIDGE, UB11 1FG, UNITED KINGDOM |
| 4. Address(es) of site(s) where registered activities take place |
KUEHNE + NAGEL (UK) LIMITED, UNIT 1, HEATHROW SOUTH CARGO CENTRE, GIRLING WAY, FELTHAM, TW14 0PH, UNITED KINGDOM |
| 5. National legal basis of registration |
Regulation 327 of The Human Medicines Regulations 2012 (SI 2012/1916)
|
| 6. Name of responsible officer of the competent authority of the member state validating the registration | Confidential |
| 7. Date | 25/07/2024 |
This registration form is valid only when presented with all pages. The authenticity of this registration form may be verified in MHRA-GMDP.
The registration holder referred to in section 2 shall communicate annually to the competent authority an inventory of the changes which have taken place as regards the information provided in this registration form. Any changes that may have an impact on the quality or safety of the listed active substances must be notified immediately.
SCOPE OF REGISTRATION
KUEHNE + NAGEL (UK) LIMITED, UNIT 1, HEATHROW SOUTH CARGO CENTRE, GIRLING WAY, FELTHAM, TW14 0PH, UNITED KINGDOM
| 2. IMPORTATION AND DISTRIBUTION OPERATIONS | |||
| B | Distribution | ||
| FLUTICASONE PROPIONATE (2000008220) | |||
| CEFUROXIME AXETIL (2000008117) | |||
| VILANTEROL TRIFENATATE (4000013535) | |||
| LACIDIPINE (1000007375) | |||
| NALOXONE HYDROCHLORIDE (2000008238) | |||
| DOLUTEGRAVIR (1000018949) | |||
| POTASSIUM CLAVULANATE (2000007982) | |||
| FILGRASTIM (1000009495) | |||
| CABOTEGRAVIR (1000017903) | |||
| NALOXONE HYDROCHLORIDE DIHYDRATE (4000006155) | |||
| FOSTEMSAVIR TROMETHAMINE (2000019620) | |||
| BUPRENORPHINE HYDROCHLORIDE (2000008277) | |||
| ZANAMIVIR (1000000992) | |||
| FLUTICASONE FUROATE (2000014516) | |||
| ABACAVIR SULFATE (4000003016) | |||
| BETAMETHASONE VALERATE (2000008358) | |||
| BUPRENORPHINE (1000007171) | |||
| UMECLIDINIUM BROMIDE (4000014045) | |||
| SALMETEROL XINAFOATE (2000008392) | |||
| CLOBETASONE BUTYRATE (2000008013) | |||
| ZIDOVUDINE (1000009208) | |||
| CEFUROXIME SODIUM (2000008116) | |||
| CLOBETASOL PROPIONATE (2000008014) | |||
| SALBUTAMOL SULPHATE (2000007742) | |||
| FOSAMPRENAVIR CALCIUM (2000007214) | |||
| LAPATINIB (1000010613) | |||
| ELTROMBOPAG OLAMINE (2000018050) | |||
| DABRAFENIB MESYLATE (2000017501) | |||